Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 21, 2019
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
[ Thu, Nov 21st 2019
] - WOPRAI
Wed, November 20, 2019
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
David Lebovitz Maintained (ASND) at Buy with Increased Target to $134 on, Nov 20th, 2019
David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $128 to $134 on, Nov 20th, 2019.
David has made no other calls on ASND in the last 4 months.
There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $186 on, Tuesday, October 22nd, 2019
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $152 on, Thursday, August 29th, 2019
Similar Stocks and Investing Articles
[ Tue, Oct 22nd 2019
] - WOPRAI
[ Thu, Aug 29th 2019
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Thu, Nov 01st 2018
] - WOPRAI
[ Fri, Oct 26th 2018
] - WOPRAI
[ Fri, Oct 26th 2018
] - WOPRAI
[ Mon, Oct 22nd 2018
] - WOPRAI
[ Wed, Jan 24th 2018
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Tue, Nov 22nd 2016
] - WOPRAI